Me Today Ltd
NZX:MEE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (0.7), the stock would be worth NZ$0.02 (49% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.5 | NZ$0.05 |
0%
|
| 3-Year Average | 0.7 | NZ$0.02 |
-49%
|
| 5-Year Average | 1.7 | NZ$0.05 |
+15%
|
| Industry Average | 0.9 | NZ$0.03 |
-35%
|
| Country Average | 1.8 | NZ$0.06 |
+22%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| NZ |
|
Me Today Ltd
NZX:MEE
|
4.4m NZD | 1.5 | -12.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
102.7B USD | -79.1 | 23.7 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.7B USD | 31.8 | 37.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.7B USD | 31.8 | 37.4 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
48.5B USD | -16.8 | 29.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.6B AUD | 6.5 | 35.1 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.8B CNY | 0.8 | 11 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.8B USD | 2.7 | 22.1 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
59.2B CNY | 2.5 | 20.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 6 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.5B HKD | 0.6 | 7.2 |
Market Distribution
| Min | 0.3 |
| 30th Percentile | 1 |
| Median | 1.8 |
| 70th Percentile | 3.4 |
| Max | 11.6 |
Other Multiples
Me Today Ltd
Glance View
Me Today Ltd. engages in the production of premium quality products clearly linking supplements and natural skincare, ultimately making it easier for consumers to shop. The firm is engaged in producing, selling and marketing health and wellbeing products or acting as an agent on behalf of other health and wellbeing suppliers. The company owns and operates the Me Today brand. The firm also produces and sells manuka honey. Its segments include Sale of goods, Agency services, Honey and Others. Its products include Women’s Daily, Energize, Goodnight, Beauty, Men’s Daily, Becalm, Focus, Serum, Moisturizer, Face Mask, Eye Cream, Lip Balm, Hand Wash, Hand Lotion, Mist Toner, Night Cream, Micellar Gel, Cream Cleanser, among others. Its products are formulated using absorbable ingredients and are either vegetarian or vegan-friendly. Its subsidiaries include The Good Brand Company Limited, Me Today NZ Limited, King Honey Limited, Me Today Manuka Honey Limited and others.
